We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microneedle Skin Patch Collects Fluid for Diagnostic Testing

By HospiMedica International staff writers
Posted on 18 Jun 2019
A new study describes how a paper-based skin patch that contains tiny needles painlessly collects interstitial fluid (ISF) for biomarker analysis.

Developed at Washington University (WUSTL; St. More...
Louis, MO, USA) and the Georgia Institute of Technology (Georgia Tech; Atlanta, GA, USA), the patch’s micrometer-scale microneedles puncture the skin, creating tiny micropores in the surface through which small quantities of ISF leak. The ISF is subsequently collected onto a strip of plasmonic paper that forms part of the backing of the patch. It is then analyzed in-situ, using surface-enhanced Raman scattering (SERS), in order to detect and measure pharmacokinetic profiles.

For the study, the researchers immobilized negatively charged poly(styrenesulfonate) (PSS) coated gold nanorods on a thin strip of filter paper using plasmonic calligraphy. A positively charged dye containing rhodamine 6G (R6G) was then injected into a rats' bloodstream. The dye entered the ISF and from there to the microneedle patch and onto the plasmonic paper, where it bound to the negatively charged PSS, and then analyzed with SERS. The researchers found that the new method could detect the R6G dye as sensitively as previous multi-step procedures. The study was published on May 9, 2019, in ACS Sensors.

“This proof-of-concept study indicates that a plasmonic paper microneedle patch has the potential to enable on-patch measurement of molecules in ISF for research and future medical applications,” concluded lead author Chandana Kolluru, PhD, of the Georgia Tech School of Materials Science and Engineering, and colleagues.

ISF surrounds all tissue cells and is present in the skin. It is advantageous for biosensing applications since it does not contain any particulates (red blood cells or platelets), and contains at least 5–10 times less protein than blood serum. However, only extremely low volumes can be found on the skin, making the process of ISF extraction rather difficult. ISF extraction using microneedles combined with integrated biosensing capabilities could provide significant opportunities for minimally invasive monitoring and diagnostics, such as in diabetes.

Related Links:
Washington University 
Georgia Institute of Technology


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Immobilization System
Cranial 4Pi Immobilization
New
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.